Clinical Trial Detail

NCT ID NCT01730950
Title Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Radiation Therapy Oncology Group
Indications

giant cell glioblastoma

gliosarcoma

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.